Categories
Article Boron Compounds Boron Determination Chemistry In-vitro Studies Year 2020

Ruthenium carboranyl complexes with 2,2’-bipyridine derivatives for potential bimodal therapy application

RSC Advances, 2020

Categories
Article Boron Compounds Chemistry In-vitro Studies In-vivo Studies Radiobiology Year 2020

Sunitinib containing carborane pharmacophore with ability to inhibit tyrosine kinases receptors, FLT3, KIT, and PDGFR-β, exhibits powerful in vivo anti-glioblastoma activity

Cancers, 2020

Categories
Article Boron Compounds Boron Determination Chemistry In-vitro Studies Radiobiology Year 2020

Closo-carboranyl- and Metallacarboranyl[1,2,3]-triazolyl-decorated Lapatinib-scaffold for Cancer Therapy Combining Tyrosine Kinase Inhibition and Boron Neutron Capture Therapy

Cells, 2020

Categories
Article Boron Compounds Chemistry In-vitro Studies Radiobiology Year 2020

Bimodal Therapeutic Agent against Glioblastoma, one the most Lethal Cancer

Chemistry European Journal, 2020

Categories
Article Boron Compounds Chemistry Year 2020

Too Persistent to Give Up: Aromaticity in Boron Clusters Survives Radical Structural Changes

Journal of the American Chemical Society, 2020

Categories
Article Biology Boron Determination Boron imaging In-vitro Studies In-vivo Studies Year 2020

Glioma stem-like cells can be targeted in boron neutron capture therapy with boronophenylalanine

Cancers, 2020

Categories
Article Radiobiology Review Year 2020

An attempt to improve the therapeutic effect of boron neutron capture therapy using commonly employed 10B-carriers based on analytical studies on the correlation among quiescent tumor cell characteristics, tumor heterogeneity and cancer stemness

Journal of Radiation Research, 2020

Categories
Article Chemistry Small Boron compounds Year 2020

Experimental studies of boron neutron capture therapy (BNCT) using histone deacetylase inhibitor (HDACI) sodium butyrate, as a complementary drug for the treatment of poorly differentiated thyroid cancer (PDTC)

Applied Radiation and Isotopes, 2020

Categories
Article Clinical trials Phase II Studies Toxicity Year 2020

Boron neutron capture therapy using cyclotron-based epithermal neutron source and borofalan (10B) for recurrent or locally advanced head and neck cancer (JHN002): An open-label phase II trial

Radiotherapy and Oncology, 2020